Does the learned intermediary rule protect pharmacists from all negligence claims? Jensen v. Walgreen Co. Explained

In Jensen v. Walgreen Co., the Utah Supreme Court clarified important limitations on the learned intermediary rule in negligence claims against pharmacists, holding that the rule does not apply when pharmacists have knowledge of patient-specific risks.

Background and Facts

Steven Jensen took oxycodone for chronic pain management for many years. When his doctor prescribed clonazepam for anxiety, Jensen went to Walgreens to fill the prescription. The combination of oxycodone and clonazepam carries serious health risks, including death, prompting the FDA to require a black box warning. When the pharmacist entered the prescription, a computer warning flagged the dangerous interaction, but the pharmacist manually overrode the warning and filled the prescription without contacting the prescribing physician or warning Jensen. Jensen died less than thirty-six hours later from oxycodone and clonazepam toxicity.

Key Legal Issues

The central issue was whether the learned intermediary rule shields pharmacists from negligence liability when they fill prescriptions exactly as written by physicians. Walgreens argued that under this rule, only the prescribing physician had a duty to warn patients of drug risks. The court also addressed whether causation issues warranted summary judgment.

Court’s Analysis and Holding

The court distinguished between general drug risks and patient-specific risks. While the learned intermediary rule exempts pharmacists from warning patients about general risks of FDA-approved drugs, it does not create an exception to a pharmacist’s general duty of care when the pharmacist has knowledge of patient-specific risks. The court noted that imposing a duty to warn in such circumstances would not require pharmacists to intrude into the doctor-patient relationship or practice medicine without a license, as the pharmacist already possessed the relevant risk information.

Practice Implications

This decision significantly narrows the scope of protection offered by the learned intermediary rule in negligence cases. Pharmacists remain subject to their general standard of care when they have knowledge of patient-specific contraindications, drug interactions, or prescription errors apparent on the face of the prescription. The ruling also reinforces that genuine disputes of material fact regarding causation will defeat summary judgment motions in pharmaceutical negligence cases.